Predicting the Safety of FDA Regulated Products with Metabolomics
Laura Schnackenberg, Center for Metabolomics Research, speaks at Advances in Metabolic Profiling 2005.
The Application of Metabolic Profiling Techniques in Biomarker Discovery in Drug R&D
Dr. Ina Schuppe Koistinen, AstraZeneca R&D speaking at Advances in Metabolic Profiling 2005
Metabolomics as a Tool for Biomarker Discovery
Dr. Chris Beecher, Vice President of Biochemistry and Technology, Metabolon, Inc., speaking at Advances in Metabolic Profiling 2005
|<< || 1 2 3 4 5 6 7 ||>>|
|Showing Results 61 - 63 of 63|